PuSH - Publikationsserver des Helmholtz Zentrums München

29 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Thomas, J. et al.: Is the humoral immunity dispensable for the pathogenesis of psoriasis? J. Eur. Acad. Dermatol. Venereol. 33, 115-122 (2019)
2.
Thomas, J. et al.: Foxo4 and AHR control a stress-induced immune-mediated host protection via secretion of IL-22. Exp. Dermatol. 28, E76-E77 (2019)
3.
Baghin, V.* et al.: Predictive models for the natural course of atopic dermatitis in childhood based on serum parameters and clinical attributes. Exp. Dermatol. 27, E17-E17 (2018)
4.
Garzorz-Stark, N.* et al.: Toll-like receptor 7/8 agonists stimulate plasmacytoid dendritic cells to initiate T(H)17-deviated acute contact dermatitis in human subjects. J. Allergy Clin. Immunol. 141, 1320-1333.e11 (2018)
5.
Jargosch, M.* et al.: Necroptosis as special type of cell death in inflammatory skin diseases. J. Invest. Dermatol. 138, S116-S116 (2018)
6.
Jargosch, M.* et al.: Necroptosis as special type of cell death in inflammatory skin diseases. Allergy 73, 731-731 (2018)
7.
Krause, L. et al.: Mathematical concepts and their challenges in predicting severity of atopic eczema patients. Allergy 73, 731-731 (2018)
8.
Lauffer, F.* et al.: Type I immune response induces keratinocyte necroptosis and is associated with interface dermatitis. J. Invest. Dermatol., accepted (2018)
9.
Thomas, J. et al.: The role of humoral immunity in the pathogenesis of psoriasis. Allergy 73, 732-733 (2018)
10.
Garzorz-Stark, N. et al.: The imiquimod model as a model for psoriasis and/or eczema in humans? Exp. Dermatol. 26, E68-E68 (2017)
11.
Garzorz-Stark, N.* et al.: TLR7/8 agonists stimulate plasmacytoid dendritic cells to initiate a Th17-deviated acute contact dermatitis in humans. J. Invest. Dermatol. 137, S275-S275 (2017)
12.
Kuepper, M.K.* et al.: Characterization of multiple B cell subsets in peripheral blood and skin biopsies of psoriasis patients identifies a correlation of plasma and regulatory B cells and disease severity. Exp. Dermatol. 26, E69-E70 (2017)
13.
Lauffer, F.* et al.: Interface dermatitis shows a distinctive molecular signature independent from individual disease background. Exp. Dermatol. 26, E61-E61 (2017)
14.
Lauffer, F.* et al.: Interface Dermatitis is characterized by a type I immune response and an epidermal reaction to IFN-gamma and TNF-alpha. J. Invest. Dermatol. 137, S254-S254 (2017)
15.
Milger, K. et al.: Identification of a plasma miRNA biomarker-signature for allergic asthma: A translational approach. Allergy 72, 1962-1971 (2017)
16.
Garzorz-Stark, N.* et al.: A novel molecular disease classifier for psoriasis and eczema. Exp. Dermatol. 25, 767-774 (2016)
17.
Graessel, A. et al.: Identification of new cell surface targets on human T helper cells. J. Invest. Dermatol. 136, S232-S232 (2016)
18.
Graessel, A. ; Krause, L. ; Suttner, K. ; Schmidt-Weber, C.B. & Blank, S.: Searching for drug targets - Are Solute Carrier (SLC) transport proteins a promising target on human naive and activated CD4+T cells. Allergy 71, 223-224 (2016)
19.
Krause, L. et al.: A computational model to predict severity of atopic eczema from 30 serum proteins. J. Allergy Clin. Immunol. 138, 1207-1210.e2 (2016)
20.
Krause, L. ; Müller, N.S. & Eyerich, S.: Reply. J. Allergy Clin. Immunol. 139, 1065-1066 (2016)